Naproxen Sodium (2 x 220 mg) Fasted Comparative Bioavailability Study

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 12, 2016

Primary Completion Date

December 2, 2016

Study Completion Date

December 2, 2016

Conditions

Healthy

Interventions

DRUG

Test

RB naproxen sodium tablets (2x220mg)

DRUG

Reference

Aleve naproxen sodium tablets (2x220mg)

All Listed Sponsors

collaborator

Simbec Research

INDUSTRY

lead

Reckitt Benckiser Healthcare (UK) Limited

INDUSTRY

NCT03167541 - Naproxen Sodium (2 x 220 mg) Fasted Comparative Bioavailability Study | Biotech Hunter | Biotech Hunter